{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T10:06:12Z","timestamp":1789380372475,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-19721-0","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T09:38:01Z","timestamp":1789378681000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Value of preoperative peripheral blood inflammation markers in predicting prognosis after radical gastric cancer surgery"],"prefix":"10.1038","volume":"16","author":[{"given":"Xiang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LianWei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongxue","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"issue":"3","key":"19721_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74 (3), 229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834 (2024).","journal-title":"CA Cancer J. Clin."},{"issue":"11","key":"19721_CR2","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1007\/s11427-022-2240-6","volume":"66","author":"Y Wang","year":"2023","unstructured":"Wang, Y. et al. Overview and countermeasures of cancer burden in China. Sci. China Life Sci. 66 (11), 2515\u20132526. https:\/\/doi.org\/10.1007\/s11427-022-2240-6 (2023).","journal-title":"Sci. China Life Sci."},{"key":"19721_CR3","doi-asserted-by":"publisher","first-page":"101003","DOI":"10.1016\/j.lanwpc.2023.101003","volume":"44","author":"F He","year":"2024","unstructured":"He, F. et al. Trends of gastric cancer burdens attributable to risk factors in China from 2000 to 2050. Lancet Reg. Health West. Pac. 44, 101003. https:\/\/doi.org\/10.1016\/j.lanwpc.2023.101003 (2024).","journal-title":"Lancet Reg. Health West. Pac."},{"key":"19721_CR4","doi-asserted-by":"publisher","first-page":"744839","DOI":"10.3389\/fmed.2021.744839","volume":"8","author":"ZD Chen","year":"2021","unstructured":"Chen, Z. D. et al. Recent advances in the diagnosis, staging, treatment, and prognosis of advanced gastric cancer: A literature review. Front. Med. (Lausanne). 8, 744839. https:\/\/doi.org\/10.3389\/fmed.2021.744839 (2021).","journal-title":"Front. Med. (Lausanne)"},{"issue":"10251","key":"19721_CR5","first-page":"635","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth, E. C. et al. Gastric Cancer Lancet ;396(10251):635\u2013648. (2020).","journal-title":"Gastric Cancer Lancet"},{"issue":"1","key":"19721_CR6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13045-023-01407-7","volume":"16","author":"Z Zhang","year":"2023","unstructured":"Zhang, Z., Li, X., Wang, Y., Wei, Y. & Wei, X. Involvement of inflammasomes in tumor microenvironment and tumor therapies. J. Hematol. Oncol. 16 (1), 24. https:\/\/doi.org\/10.1186\/s13045-023-01407-7 (2023).","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"19721_CR7","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","volume":"6","author":"H Zhao","year":"2021","unstructured":"Zhao, H. et al. Inflammation and tumor progression: signaling pathways and targeted intervention. Signal. Transduct. Target. Ther. 6 (1), 263. https:\/\/doi.org\/10.1038\/s41392-021-00658-5 (2021).","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"1","key":"19721_CR8","first-page":"5","volume":"102","author":"R Zahorec","year":"2001","unstructured":"Zahorec, R. Ratio of neutrophil to lymphocyte counts\u2013rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy. 102 (1), 5\u201314 (2001).","journal-title":"Bratisl Lek Listy"},{"issue":"1","key":"19721_CR9","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12957-020-01952-2","volume":"18","author":"X Zhang","year":"2020","unstructured":"Zhang, X. et al. Clinicopathological and prognostic significance of platelet-lymphocyte ratio (PLR) in gastric cancer: an updated meta-analysis. World J. Surg. Oncol. 18 (1), 191. https:\/\/doi.org\/10.1186\/s12957-020-01952-2 (2020).","journal-title":"World J. Surg. Oncol."},{"key":"19721_CR10","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.2147\/OTT.S140118","volume":"10","author":"L Chen","year":"2017","unstructured":"Chen, L. et al. Monocyte to lymphocyte ratio predicts survival in patients with advanced gastric cancer undergoing neoadjuvant chemotherapy. Onco Targets Ther. 10, 4007\u20134016. https:\/\/doi.org\/10.2147\/OTT.S140118 (2017).","journal-title":"Onco Targets Ther."},{"issue":"23","key":"19721_CR11","doi-asserted-by":"publisher","first-page":"6212","DOI":"10.1158\/1078-0432.CCR-14-0442","volume":"20","author":"B Hu","year":"2014","unstructured":"Hu, B. et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin. Cancer Res. 20 (23), 6212\u20136222. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-0442 (2014).","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"19721_CR12","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2217\/fon.09.136","volume":"6","author":"CS Roxburgh","year":"2010","unstructured":"Roxburgh, C. S. & McMillan, D. C. Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol. 6 (1), 149\u2013163 (2010).","journal-title":"Future Oncol."},{"issue":"1","key":"19721_CR13","doi-asserted-by":"crossref","first-page":"12164","DOI":"10.1038\/s41598-020-69039-2","volume":"10","author":"S Li","year":"2020","unstructured":"Li, S. et al. Prognostic value of pretreatment hematological markers in gastric cancer patients and the establishment of a nomogram. Sci. Rep. 10 (1), 12164 (2020).","journal-title":"Sci. Rep."},{"issue":"5","key":"19721_CR14","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144 (5), 646\u2013674. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013 (2011).","journal-title":"Cell"},{"issue":"5","key":"19721_CR15","first-page":"2569","volume":"40","author":"N Hirahara","year":"2020","unstructured":"Hirahara, N. et al. Prognostic value of inflammatory and nutritional blood-based markers in gastric cancer patients. Anticancer Res. 40 (5), 2569\u20132580 (2020).","journal-title":"Anticancer Res."},{"issue":"10","key":"19721_CR16","first-page":"1748","volume":"35","author":"K Gonda","year":"2020","unstructured":"Gonda, K. et al. Clinical significance of pretreatment hematologic parameters in patients undergoing surgery for gastric cancer. J. Gastroenterol. Hepatol. 35 (10), 1748\u20131757 (2020).","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"5","key":"19721_CR17","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/jso.24992","volume":"117","author":"W Guo","year":"2018","unstructured":"Guo, W. et al. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in advanced gastric cancer patients treated with neoadjuvant chemotherapy. J. Surg. Oncol. 117 (5), 912\u2013918 (2018).","journal-title":"J. Surg. Oncol."},{"issue":"3","key":"19721_CR18","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin, P. C. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar. Behav. Res. 46 (3), 399\u2013424 (2011).","journal-title":"Multivar. Behav. Res."},{"key":"19721_CR19","doi-asserted-by":"publisher","first-page":"9146042","DOI":"10.1155\/2020\/9146042","volume":"2020","author":"T Fang","year":"2020","unstructured":"Fang, T. et al. Diagnostic sensitivity of NLR and PLR in early diagnosis of gastric cancer. J. Immunol. Res. 2020, 9146042 (2020).","journal-title":"J. Immunol. Res."},{"issue":"2","key":"19721_CR20","first-page":"93","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin, M. B. et al. The eighth edition AJCC cancer staging manual: continuing to build a Bridge from a population-based to a more personalized approach to cancer staging. CA Cancer J. Clin. 67 (2), 93\u201399 (2017).","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"19721_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.6004\/jnccn.2022.0008","volume":"20","author":"JA Ajani","year":"2022","unstructured":"Ajani, J. A. et al. Gastric cancer, version 2.2022, NCCN clinical practice guidelines in oncology. J. Natl. Compr. Canc Netw. 20 (2), 167\u2013192 (2022).","journal-title":"J. Natl. Compr. Canc Netw."},{"issue":"38","key":"19721_CR22","doi-asserted-by":"publisher","first-page":"41370","DOI":"10.18632\/oncotarget.5629","volume":"6","author":"XL Chen","year":"2015","unstructured":"Chen, X. L. et al. Prognostic significance of the combination of preoperative hemoglobin, albumin, lymphocyte and platelet in patients with gastric carcinoma: a retrospective cohort study. Oncotarget 6 (38), 41370\u201341382. https:\/\/doi.org\/10.18632\/oncotarget.5629 (2015).","journal-title":"Oncotarget"},{"key":"19721_CR23","doi-asserted-by":"publisher","first-page":"101911","DOI":"10.1016\/j.suronc.2023.101911","volume":"47","author":"K Furukawa","year":"2023","unstructured":"Furukawa, K. et al. Impact of C-reactive protein-albumin-lymphocyte (CALLY) index on prognosis after hepatectomy for colorectal liver metastasis. Surg. Oncol. 47, 101911. https:\/\/doi.org\/10.1016\/j.suronc.2023.101911 (2023).","journal-title":"Surg. Oncol."},{"issue":"4","key":"19721_CR24","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1080\/01635581.2019.1577986","volume":"71","author":"J Li","year":"2019","unstructured":"Li, J. et al. Prognostic nutritional index predicts outcomes of patients after gastrectomy for cancer: A systematic review and Meta-Analysis of nonrandomized studies. Nutr. Cancer. 71 (4), 557\u2013568. https:\/\/doi.org\/10.1080\/01635581.2019.1577986 (2019).","journal-title":"Nutr. Cancer"},{"key":"19721_CR25","doi-asserted-by":"publisher","first-page":"5439","DOI":"10.2147\/JIR.S476346","volume":"17","author":"X Li","year":"2024","unstructured":"Li, X., Zhang, J. & Fu, Z. Development and validation of an inflammation-combined prognostic index (ICPI)-based nomogram for predicting overall survival in gastric cancer. J Inflamm Res 17, 5439\u20135452. https:\/\/doi.org\/10.2147\/JIR.S476346 (2024).","journal-title":"J Inflamm Res"},{"key":"19721_CR26","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1471-2407-13-52","volume":"13","author":"A Kinoshita","year":"2013","unstructured":"Kinoshita, A. et al. The Glasgow prognostic score, an inflammation based prognostic score, predicts survival in patients with hepatocellular carcinoma. BMC Cancer. 13, 52\u201352. https:\/\/doi.org\/10.1186\/1471-2407-13-52 (2013).","journal-title":"BMC Cancer"},{"issue":"1","key":"19721_CR27","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12957-023-02926-w","volume":"21","author":"L Yu","year":"2023","unstructured":"Yu, L. et al. Novel prognostic indicator combining inflammatory indicators and tumor markers for gastric cancer. World J. Surg. Oncol. 21 (1), 50. https:\/\/doi.org\/10.1186\/s12957-023-02926-w (2023).","journal-title":"World J. Surg. Oncol."},{"issue":"2","key":"19721_CR28","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/s12350-017-1012-y","volume":"25","author":"CJ Morgan","year":"2018","unstructured":"Morgan, C. J. Reducing bias using propensity score matching. J. Nucl. Cardiol. 25 (2), 404\u2013406. https:\/\/doi.org\/10.1007\/s12350-017-1012-y (2018).","journal-title":"J. Nucl. Cardiol."},{"issue":"1","key":"19721_CR29","doi-asserted-by":"publisher","first-page":"16","DOI":"10.21037\/atm.2018.12.10","volume":"7","author":"Z Zhang","year":"2019","unstructured":"Zhang, Z., Kim, H. J., Lonjon, G., Zhu, Y. & written on behalf of AME Big-Data Clinical Trial Collaborative Group. Balance diagnostics after propensity score matching. Ann. Transl Med. 7 (1), 16. https:\/\/doi.org\/10.21037\/atm.2018.12.10 (2019).","journal-title":"Ann. Transl Med."},{"issue":"4","key":"19721_CR30","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/bimj.200410135","volume":"47","author":"R Fluss","year":"2005","unstructured":"Fluss, R., Faraggi, D. & Reiser, B. Estimation of the Youden index and its associated cutoff point. Biom J. 47 (4), 458\u2013472. https:\/\/doi.org\/10.1002\/bimj.200410135 (2005).","journal-title":"Biom J."},{"issue":"21","key":"19721_CR31","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","volume":"10","author":"RL Camp","year":"2004","unstructured":"Camp, R. L., Dolled-Filhart, M. & Rimm, D. L. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res 10(21), 7252\u20139. https:\/\/doi.org\/10.1158\/1078-0432.CCR-04-0713 (2004) (PMID: 15534099).","journal-title":"Clin Cancer Res"},{"issue":"19","key":"19721_CR32","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1002\/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B","volume":"17","author":"RB D\u2019Agostino Jr","year":"1998","unstructured":"D\u2019Agostino, R. B. Jr Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat. Med. 17 (19), 2265\u20132281 (1998).","journal-title":"Stat. Med."},{"issue":"9","key":"19721_CR33","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.4251\/wjgo.v15.i9.1626","volume":"15","author":"Y Duzkopru","year":"2023","unstructured":"Duzkopru, Y. et al. Hemoglobin, albumin, lymphocyte, and platelet score as a predictor of prognosis in metastatic gastric cancer. World J. Gastrointest. Oncol. 15 (9), 1626\u20131635. https:\/\/doi.org\/10.4251\/wjgo.v15.i9.1626 (2023).","journal-title":"World J. Gastrointest. Oncol."},{"issue":"2","key":"19721_CR34","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.smim.2016.03.018","volume":"28","author":"K Moses","year":"2016","unstructured":"Moses, K. & Brandau, S. Human neutrophils: their role in cancer and relation to Myeloid-Derived suppressor cells. Semin Immunol. 28 (2), 187\u2013196. https:\/\/doi.org\/10.1016\/j.smim.2016.03.018 (2016).","journal-title":"Semin Immunol."},{"key":"19721_CR35","doi-asserted-by":"publisher","first-page":"7165","DOI":"10.4049\/jimmunol.0902583","volume":"185","author":"S Augier","year":"2010","unstructured":"Augier, S. et al. Inflammatory blood monocytes contribute to tumor development and represent a privileged target to improve host immunosurveillance. J. Immunol. 185, 7165\u20137173. https:\/\/doi.org\/10.4049\/jimmunol.0902583 (2010).","journal-title":"J. Immunol."},{"issue":"2","key":"19721_CR36","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2174\/156800912799095144","volume":"12","author":"SA Kono","year":"2012","unstructured":"Kono, S. A., Heasley, L. E., Doebele, R. C. & Camidge, D. R. Adding to the mix: fibroblast growth factor and platelet-derived growth factor receptor pathways as targets in non-small cell lung cancer. Curr. Cancer Drug Targets. 12 (2), 107\u2013123. https:\/\/doi.org\/10.2174\/156800912799095144 (2012).","journal-title":"Curr. Cancer Drug Targets"},{"issue":"1","key":"19721_CR37","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2217\/fon.09.136","volume":"6","author":"CS Roxburgh","year":"2010","unstructured":"Roxburgh, C. S. & McMillan, D. C. Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol. 6 (1), 149\u2013163. https:\/\/doi.org\/10.2217\/fon.09.136 (2010).","journal-title":"Future Oncol."},{"issue":"10","key":"19721_CR38","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/nrclinonc.2015.105","volume":"12","author":"SM Crusz","year":"2015","unstructured":"Crusz, S. M. & Balkwill, F. R. Inflammation and cancer: advances and new agents. Nat. Rev. Clin. Oncol. 12 (10), 584\u2013596. https:\/\/doi.org\/10.1038\/nrclinonc.2015.105 (2015).","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"19721_CR39","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12893-023-02001-x","volume":"23","author":"W Ren","year":"2023","unstructured":"Ren, W. et al. Clinical significance of prognostic nutritional index (PNI)-monocyte-to-lymphocyte ratio (MLR)-platelet (PLT) score on postoperative outcomes in non-metastatic clear cell renal cell carcinoma. BMC Surg. 23 (1), 117. https:\/\/doi.org\/10.1186\/s12893-023-02001-x (2023).","journal-title":"BMC Surg."},{"issue":"1","key":"19721_CR40","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1186\/s12885-023-11058-z","volume":"23","author":"J Liu","year":"2023","unstructured":"Liu, J. et al. Prognostic models for upper urinary tract urothelial carcinoma patients after radical nephroureterectomy based on a novel systemic immune-inflammation score with machine learning. BMC Cancer. 23 (1), 574. https:\/\/doi.org\/10.1186\/s12885-023-11058-z (2023).","journal-title":"BMC Cancer"},{"issue":"1","key":"19721_CR41","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1186\/s12885-020-07700-9","volume":"20","author":"JY Kim","year":"2020","unstructured":"Kim, J. Y. et al. Dynamic changes of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio predicts breast cancer prognosis. BMC Cancer. 20 (1), 1206. https:\/\/doi.org\/10.1186\/s12885-020-07700-9 (2020).","journal-title":"BMC Cancer"},{"issue":"1","key":"19721_CR42","doi-asserted-by":"publisher","first-page":"16717","DOI":"10.1038\/s41598-017-16955-5","volume":"7","author":"RD Dolan","year":"2017","unstructured":"Dolan, R. D., Lim, J., McSorley, S. T., Horgan, P. G. & McMillan, D. C. The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: systematic review and meta-analysis. Sci. Rep. 7 (1), 16717. https:\/\/doi.org\/10.1038\/s41598-017-16955-5 (2017).","journal-title":"Sci. Rep."},{"key":"19721_CR43","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.3389\/fonc.2020.01432","volume":"10","author":"XH Song","year":"2020","unstructured":"Song, X. H. et al. Prognostic value of changes in preoperative and postoperative serum CA19-9 levels in gastric cancer. Front. Oncol. 10, 1432. https:\/\/doi.org\/10.3389\/fonc.2020.01432 (2020).","journal-title":"Front. Oncol."},{"issue":"1","key":"19721_CR44","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12893-022-01667-z","volume":"22","author":"C Shibata","year":"2022","unstructured":"Shibata, C. et al. Comparison of CEA and CA19-9 as a predictive factor for recurrence after curative gastrectomy in gastric cancer. BMC Surg. 22 (1), 213. https:\/\/doi.org\/10.1186\/s12893-022-01667-z (2022).","journal-title":"BMC Surg."},{"issue":"10","key":"19721_CR45","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1007\/s00595-021-02248-y","volume":"51","author":"J Moriyama","year":"2021","unstructured":"Moriyama, J. et al. Prognostic impact of CEA\/CA19-9 at the time of recurrence in patients with gastric cancer. Surg. Today. 51 (10), 1638\u20131648. https:\/\/doi.org\/10.1007\/s00595-021-02248-y (2021).","journal-title":"Surg. Today"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19721-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19721-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19721-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T09:38:03Z","timestamp":1789378683000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19721-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["19721"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-19721-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,14]]},"assertion":[{"value":"20 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study adhered to the guiding principles of the Declaration of Helsinki (2013 revision). It was reviewed and approved by the Ethics Committee of the First Affiliated Hospital of Chongqing Medical University (K2023-542) and the Ethics Committee of Chongqing University Fuling Hospital (2024CDFSFLYYEC-011). Considering that this study is a retrospective analysis, the need for informed consent was waived by the Ethics Committee of the First Affiliated Hospital of Chongqing Medical University and Chongqing University Fuling Hospital.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have read and approved the final version of this manuscript, and consent to its publication in Journal of Translational Medicine.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"28600"}}